FOLH1 and neoplasm: The authors tested their PCa targeting C’ dots in a mouse model (male NOD SCID, 6–8 weeks old) using tumor xenografts established by injection of LNCaP (PSMA+) and PC3 (PSMA-) cells subcutaneously.